Literature DB >> 1499945

Survival and causes of death in patients with inflammatory bowel disease: a population-based study.

A Ekbom1, C G Helmick, M Zack, L Holmberg, H O Adami.   

Abstract

Relative survival up to December 31, 1986 was analyzed for all patients diagnosed with ulcerative colitis (UC) (n = 2,509) and Crohn's disease (CD) (n = 1,469) within the Uppsala Region, Sweden 1965-1983. After 10 years survival was 96% of that expected for UC and CD. Patients with ulcerative proctitis, left-sided colitis, and pancolitis at diagnosis had relative survival rates of 98%, 96%, and 93% respectively. Survival did not differ by extent at diagnosis for patients with CD. After including prevalent cases, 684 deaths occurred compared with 481.1 expected deaths [standardized mortality ratio (SMR) = 1.4; 95% confidence interval (CI) = 1.3-1.5]. Inflammatory bowel disease was the main reason for this excess mortality. Colorectal cancer increased mortality (50 deaths observed vs. 15.2 expected). Death from other cancers were not greater than expected. Obstructive respiratory diseases, especially bronchitis, emphysema, and asthma increased mortality SMR = 1.5 (95% CI = 1.1-2.2) in UC. Cerebrovascular disease mortality occurred less often than expected (SMR = 0.7; 95% CI = 0.5-1.0). Mortality for other diseases and groups of diseases was close to that expected.

Entities:  

Mesh:

Year:  1992        PMID: 1499945     DOI: 10.1016/0016-5085(92)90029-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  49 in total

Review 1.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease.

Authors:  W J Sandborn; E V Loftus
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

Review 3.  Association between NCF4 rs4821544T/C polymorphism and inflammatory bowel disease risk in Caucasian: a meta-analysis.

Authors:  Peng-Bo Wu; Jin-Fen Dai; Qian Wang; Guo Zhang; Shi-Yun Tan; Ming Li; Hui-Lan Ye
Journal:  Inflamm Res       Date:  2015-08-20       Impact factor: 4.575

4.  Current trends in inflammatory bowel disease: the natural history.

Authors:  Ebbe Langholz
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

5.  Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.

Authors:  F L Wolters; M G Russel; J Sijbrandij; L J Schouten; S Odes; L Riis; P Munkholm; P Bodini; C O'Morain; I A Mouzas; E Tsianos; S Vermeire; E Monteiro; C Limonard; M Vatn; G Fornaciari; S Pereira; B Moum; R W Stockbrügger
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

Review 6.  Crohn's disease: why the disparity in mortality?

Authors:  E V Loftus
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

7.  Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD.

Authors:  Anders Ekbom; Lena Brandt; Fredrik Granath; Claes-Göran Löfdahl; Arne Egesten
Journal:  Lung       Date:  2008-03-11       Impact factor: 2.584

8.  Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.

Authors:  Angelica Nocerino; Alexandra Feathers; Elena Ivanina; Laura Durbin; Arun Swaminath
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

9.  Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Authors:  Meenakshi Bewtra; Lisa M Kaiser; Tom TenHave; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

10.  Medical treatment of ulcerative colitis.

Authors:  Uma Mahadevan
Journal:  Clin Colon Rectal Surg       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.